2012
DOI: 10.1192/bjp.bp.111.105189
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics

Abstract: Neuroleptic malignant syndrome (NMS) is a rare, idiosyncratic reaction that has been reported in association with both firstand second-generation antipsychotic drugs. Although both the incidence of NMS 1 and NMS-related mortality 2 appear to be declining, the accurate and timely recognition of NMS remains a priority because of its potential severity and its association with long-term neuropsychiatric and physical sequelae.3,4 As classically described, NMS presents with abrupt onset of fever, autonomic instabil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
50
0
3

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(55 citation statements)
references
References 19 publications
2
50
0
3
Order By: Relevance
“…NMS is a rare and idiosyncratic reaction reported with both FGAs and SGAs reported to occur between 0.02 % and 0.25 % of patients (Trollor et al 2012 ;Zarrouf and Bhanot 2007 ;Guanci et al 2012 ). Diagnosis of NMS consists of hyperthermia (>100.4 °F or 38 °C on at least two occasions), muscle rigidity, and two of following symptoms: diaphoresis, dysphagia, incontinence, altered consciousness, hypertension (≥25 % above baseline), mutism, labile blood pressure (≥20 mmHg diastolic; ≥ 25 mmHg systolic), creatine kinase (CK) increase (>4 times the upper normal limit), tachypnea (≥50 % above baseline), and tremor or tachycardia (≥25 % above baseline) (Guanci et al 2012 ).…”
Section: Neuroleptic Malignant Syndrome (Nms)mentioning
confidence: 97%
“…NMS is a rare and idiosyncratic reaction reported with both FGAs and SGAs reported to occur between 0.02 % and 0.25 % of patients (Trollor et al 2012 ;Zarrouf and Bhanot 2007 ;Guanci et al 2012 ). Diagnosis of NMS consists of hyperthermia (>100.4 °F or 38 °C on at least two occasions), muscle rigidity, and two of following symptoms: diaphoresis, dysphagia, incontinence, altered consciousness, hypertension (≥25 % above baseline), mutism, labile blood pressure (≥20 mmHg diastolic; ≥ 25 mmHg systolic), creatine kinase (CK) increase (>4 times the upper normal limit), tachypnea (≥50 % above baseline), and tremor or tachycardia (≥25 % above baseline) (Guanci et al 2012 ).…”
Section: Neuroleptic Malignant Syndrome (Nms)mentioning
confidence: 97%
“…Therefore clozapi n e -i n d u c e d N M S m a y b e particularly difficult to detect given that tachycardia, blood p r e s s u r e d i s t u r b a n c e a n d pyrexia are common during clozapine initiation due to the effects of clozapine itself or medical complications. 4 …”
Section: Clozapine Induced Nmsmentioning
confidence: 99%
“…4 One condition, or two? Due to the differing symptomatology of the NMS episode and the malignant catatonia episode, this case could demonstrate that the two conditions are separate entities.…”
mentioning
confidence: 99%
“…NMS is more common after high-potency, first-generation antipsychotics (FGAs) like haloperidol, although it can occur with any antipsychotic (Table 1) (4,5). There is some evidence, however, that NMS after SGAs may be less likely to present with rigidity (6).…”
Section: What Key Findings Lead To the Diagnosis?mentioning
confidence: 99%